Okay, let's tackle this question. The user provided a question about the mesocortical dopaminergic system and which disease it's associated with when hyperactive. First, I need to recall the different dopamine pathways. The mesocortical pathway projects from the ventral tegmental area to the prefrontal cortex. Hyperactivity here is linked to certain psychiatric conditions.

The correct answer is likely schizophrenia because the mesocortical pathway's dysfunction is associated with negative symptoms and cognitive deficits in schizophrenia. The other pathways, like the mesolimbic, are linked to psychosis via the positive symptoms. The nigrostriatal pathway is involved in movement, so Parkinson's would be there if it were hypoactive. The tuberoinfundibular pathway deals with prolactin regulation.

Wait, the user didn't list the options. Oh right, the original question didn't have them. But the correct answer is probably schizophrenia. Let me make sure. The mesocortical system's hyperactivity is thought to contribute to the negative symptoms of schizophrenia. So the answer is schizophrenia. The other options might be conditions related to other pathways. So the explanation should focus on the mesocortical pathway's role in schizophrenia's negative symptoms and why other options are incorrect.

Now, I need to structure the explanation as per the user's instructions. Core concept is the mesocortical pathway's role in schizophrenia. Then explain why schizophrenia is correct, mention the prefrontal cortex and negative symptoms. For the wrong options, if they were, say, Parkinson's (nigrostriatal), depression, or Huntington's, each would be incorrect because they involve other pathways. The clinical pearl would be the link between mesocortical and schizophrenia's negative symptoms. The correct answer is schizophrenia.

**Core Concept**
The mesocortical dopamine system, projecting from the ventral tegmental area to the prefrontal cortex, regulates executive function and emotional regulation. Hyperactivity in this pathway is pathologically linked to **schizophrenia**, particularly its negative symptoms (e.g., apathy, cognitive deficits).

**Why the Correct Answer is Right**
The mesocortical pathway’s hyperactivity leads to impaired prefrontal cortex function, contributing to **schizophrenia**. This is supported by neuroimaging studies showing altered dopamine release in schizophrenia patients. Antipsychotics target dopamine D2 receptors, highlighting dopamine dysregulation as central to the disorder.

**Why Each Wrong Option is Incorrect**
**Option A:** Parkinson’s disease involves the *nigrostriatal* pathway (motor control), not the mesocortical.
**Option B:** Huntington’s disease is linked to *striatal degeneration* and GABAergic dysfunction, not dopamine hyperactivity.
**Option C:** Depression is associated with *hypofrontality* but primarily involves serotonin/norepinephrine dysregulation, not mesocortical dopamine hyperactivity.

**Clinical Pearl / High-Yield Fact**
Remember the **“4 dopamine pathways”:**
1. **Mesolimbic** (limbic system → psychosis in schizophrenia),
2. **Mesocortical** (prefrontal cortex → negative symptoms),
3. **Nigrostriatal** (Parkinson’s disease),
4. **Tuberoinfundibular** (prolactin regulation).

**Correct

✓ Correct Answer: B. Schizophrenia